(AMGN) Amgen - Performance 9.4% in 12m
Compare AMGN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
37.27%
#16 in Group
Rel. Strength
60.24%
#3174 in Universe
Total Return 12m
9.44%
#45 in Group
Total Return 5y
46.93%
#28 in Group
P/E 37.0
76th Percentile in Group
P/E Forward 13.4
50th Percentile in Group
PEG 0.94
87th Percentile in Group
FCF Yield 5.23%
97th Percentile in Group
12m Total Return: AMGN (9.4%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: AMGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AMGN
Total Return (including Dividends) | AMGN | XBI | S&P 500 |
---|---|---|---|
1 Month | -6.62% | 2.28% | -0.87% |
3 Months | 2.75% | -10.48% | -7.58% |
12 Months | 9.44% | -1.83% | 11.88% |
5 Years | 46.93% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | AMGN | XBI | S&P 500 |
1 Month | -56.4% | 56.6% | 23% |
3 Months | -26.7% | -89.3% | -88.5% |
12 Months | -31.3% | -42.4% | 55.1% |
5 Years | 84.1% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #146 | -8.70% | -5.81% |
3 Month | #40 | 14.8% | 11.2% |
12 Month | #47 | 11.5% | -2.18% |
5 Years | #29 | 68.4% | -30.1% |
FAQs
Does AMGN Amgen outperforms the market?
Yes,
over the last 12 months AMGN made 9.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months AMGN made 2.75%, while XBI made -10.48%.
Over the last 3 months AMGN made 2.75%, while XBI made -10.48%.
Performance Comparison AMGN vs Indeces and Sectors
AMGN vs. Indices AMGN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.12% | -5.75% | -5.81% | -2.44% |
US NASDAQ 100 | QQQ | 0.09% | -8.02% | -6.24% | -3.23% |
US Dow Jones Industrial 30 | DIA | 2.06% | -3.44% | -5.72% | 0.24% |
German DAX 40 | DAX | 2.35% | -7.94% | -25.3% | -15.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.08% | -3.80% | -2.82% | 3.48% |
Hongkong Hang Seng | HSI | 2.11% | -6.68% | -7.73% | -4.45% |
India NIFTY 50 | INDA | 3.96% | -10.7% | -6.10% | 6.37% |
Brasil Bovespa | EWZ | 1.92% | -11.2% | -9.51% | 15.3% |
AMGN vs. Sectors AMGN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.87% | -5.57% | -11.9% | -14.5% |
Consumer Discretionary | XLY | 1.04% | -6.52% | -8.32% | -3.88% |
Consumer Staples | XLP | 4.62% | -6.82% | -11.1% | -1.76% |
Energy | XLE | 5.60% | 7.24% | -0.02% | 20.5% |
Financial | XLF | 2.51% | -4.51% | -13.4% | -13.3% |
Health Care | XLV | 1.20% | -2.83% | -4.12% | 7.72% |
Industrial | XLI | 0.70% | -6.73% | -6.52% | -0.15% |
Materials | XLB | 1.73% | -4.19% | 1.60% | 13.0% |
Real Estate | XLRE | 2.64% | -5.31% | -4.92% | -8.65% |
Technology | XLK | -1.33% | -8.31% | -2.47% | 1.71% |
Utilities | XLU | 3.96% | -6.68% | -7.93% | -12.4% |
Aerospace & Defense | XAR | 0.17% | -13.0% | -19.3% | -17.1% |
Biotech | XBI | -0.18% | -8.90% | 6.83% | 11.3% |
Homebuilder | XHB | 1.81% | -4.35% | 9.00% | 16.5% |
Retail | XRT | 2.69% | -6.06% | -0.24% | 12.2% |